BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 10163666)

  • 1. Acute pulmonary effects of three nebulizers for administering aerosol pentamidine: comparison of Parineb to Fisoneb and Respirgard II.
    Chan M; Lee-Pack LR; Favell K; Chan CK
    J Aerosol Med; 1996; 9(4):521-6. PubMed ID: 10163666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of desensitization to aerosol pentamidine with long-term use.
    Rawji A; Lee-Pack LR; Favell K; Chan CK
    J Aerosol Med; 1996; 9(2):241-8. PubMed ID: 10163353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An effectiveness community-based clinical trial of Respirgard II and Fisoneb nebulizers for Pneumocystis carinii prophylaxis with aerosol pentamidine in HIV-infected individuals. Toronto Aerosol Pentamidine Study (TAPS) Group.
    McIvor RA; Berger P; Pack LL; Rachlis A; Chan CK
    Chest; 1996 Jul; 110(1):141-6. PubMed ID: 8681618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivered dose and regional distribution of aerosolized pentamidine using different delivery systems.
    Ilowite JS; Baskin MI; Sheetz MS; Abd AG
    Chest; 1991 May; 99(5):1139-44. PubMed ID: 2019169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct isotopic assessment of aerosolized pentamidine deposition: influence of nebuliser.
    Diot P; Le Pape A; Becquemin MH; Besnier JM; Boissinot E; Bastides F; Benjemaa M; Choutet P; Lemarie E
    Eur J Med; 1993; 2(8):484-8. PubMed ID: 8258049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective comparison of Porta-sonic and Fisoneb ultrasonic nebulizers for administering aerosol pentamidine.
    McIvor A; Flood D; Lee-Pack L; Rachlis A; Berger P; Chan CK; Favell K; Lewis C; Moore M; Rawji M;
    Can J Infect Dis; 1994 Mar; 5(2):62-6. PubMed ID: 22451767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of bronchospasm with regular administration of aerosolized pentamidine.
    Katzman M; Meade W; Iglar K; Rachlis A; Berger P; Chan CK
    Chest; 1992 Jan; 101(1):79-81. PubMed ID: 1729115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional deposition and regional ventilation during inhalation of pentamidine.
    O'Riordan TG; Smaldone GC
    Chest; 1994 Feb; 105(2):396-401. PubMed ID: 8306735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of particle and mass distribution of pentamidine aerosol by ultrasonic and air jet nebulizers.
    Hager J; Gober KH; Löhr JP; Dürr M
    J Aerosol Med; 1992; 5(2):65-79. PubMed ID: 10147685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal bilateral pneumothoraces following administration of aerosolised pentamidine.
    Green A; Milne N; Ong BB
    J Forensic Leg Med; 2011 Oct; 18(7):332-5. PubMed ID: 21907940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosolized pentamidine in Pneumocystis carinii pneumonia.
    On A
    Conn Med; 1990 Mar; 54(3):140-1. PubMed ID: 2182285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which apparatus for inhaled pentamidine? A comparison of pulmonary deposition via eight nebulisers.
    Thomas SH; O'Doherty MJ; Page CJ; Nunan TO; Bateman NT
    Eur Respir J; 1991 May; 4(5):616-22. PubMed ID: 1936233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute pulmonary effects of aerosolized pentamidine. A randomized controlled study. Toronto Aerosolized Pentamidine Study (TAPS) Group.
    Chest; 1990 Oct; 98(4):907-10. PubMed ID: 2209147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of nebuliser efficiency for aerosolizing pentamidine.
    Smith D; Erskine D; Steele J; Hills D; Gazzard B
    J Pharm Pharmacol; 1992 Jan; 44(1):7-9. PubMed ID: 1350636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of pentamidine nebulization in children].
    Oudyi M; Chaumuzeau JP; Diot P; Dubus JC;
    Rev Mal Respir; 2012 May; 29(5):656-63. PubMed ID: 22682591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alveolar targeting of aerosol pentamidine. Toward a rational delivery system.
    Simonds AK; Newman SP; Johnson MA; Talaee N; Lee CA; Clarke SW
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):827-9. PubMed ID: 2327646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of aerosolized pentamidine-induced bronchospasm: a symptom-based approach.
    McSharry RJ; Kirsch CM; Jensen WA; Kagawa FT
    Am J Med Sci; 1993 Jul; 306(1):20-2. PubMed ID: 8328505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lung deposition of 300 and 600 mg pentamidine, inhaled with 3 different inhalers].
    Matthys H; Herceg R
    Med Klin (Munich); 1990 Apr; 85 Suppl 2():251-4. PubMed ID: 2197532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposition of amphotericin B aerosols in pulmonary aspergilloma.
    Diot P; Rivoire B; Le Pape A; Lemarie E; Dire D; Furet Y; Breteau M; Smaldone GC
    Eur Respir J; 1995 Aug; 8(8):1263-8. PubMed ID: 7489788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro and In Vivo Comparison of Two Nebulizers Used for Inhaled Pentamidine Delivery.
    Audag N; Liistro G; Van der Linden D; Smets F; Leal T; Reychler G
    Arch Bronconeumol; 2017 Dec; 53(12):697-698. PubMed ID: 28583257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.